Allergan (AGN)
Add to Watchlists Create an AlertAllergan Enterprise Value:
28.90B for May 23, 2013Allergan Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 23, 2013 | 28.90B |
| May 22, 2013 | 28.90B |
| May 21, 2013 | 29.14B |
| May 20, 2013 | 29.12B |
| May 17, 2013 | 29.99B |
| May 16, 2013 | 29.69B |
| May 15, 2013 | 30.40B |
| May 14, 2013 | 30.69B |
| May 13, 2013 | 30.71B |
| May 10, 2013 | 30.81B |
| May 9, 2013 | 30.50B |
| May 8, 2013 | 30.55B |
| May 7, 2013 | 30.97B |
| May 6, 2013 | 30.84B |
| May 3, 2013 | 30.98B |
| May 2, 2013 | 29.96B |
| May 1, 2013 | 29.17B |
| April 30, 2013 | 33.58B |
| April 29, 2013 | 33.62B |
| April 26, 2013 | 33.12B |
| April 25, 2013 | 32.95B |
| April 24, 2013 | 32.86B |
| April 23, 2013 | 33.74B |
| April 22, 2013 | 33.74B |
| April 19, 2013 | 33.64B |
| April 18, 2013 | 33.20B |
| April 17, 2013 | 33.41B |
| April 16, 2013 | 33.46B |
| April 15, 2013 | 33.73B |
| April 12, 2013 | 34.31B |
| April 11, 2013 | 34.36B |
| April 10, 2013 | 33.95B |
| April 9, 2013 | 33.63B |
| April 8, 2013 | 33.33B |
| April 5, 2013 | 33.28B |
| April 4, 2013 | 33.84B |
| April 3, 2013 | 33.67B |
| April 2, 2013 | 33.95B |
| April 1, 2013 | 33.30B |
| March 28, 2013 | 31.90B |
| March 27, 2013 | 31.90B |
| March 26, 2013 | 31.94B |
| March 25, 2013 | 31.65B |
| March 22, 2013 | 31.98B |
| March 21, 2013 | 31.54B |
| March 20, 2013 | 31.63B |
| March 19, 2013 | 31.00B |
| March 18, 2013 | 30.97B |
| March 15, 2013 | 31.11B |
| March 14, 2013 | 31.22B |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
AGN Enterprise Value Benchmarks
| Companies | |
|---|---|
| Valeant Pharmaceuticals International | 33.04B |
| Solta Medical | 166.41M |
| Teva Pharmaceutical Industries | 44.89B |
AGN Enterprise Value Rankings
| Overall |
96th percentile 270 of 8006 |
| Sector |
96th percentile 26 of 686 in Healthcare |
| Industry |
95th percentile 3 of 68 in Drug Manufacturers - Specialty & Generic |
AGN Enterprise Value Range, Past 5 Years
| Minimum | 9.599B | Nov 20 2008 |
| Maximum | 34.36B | Apr 11 2013 |
| Average | 21.08B |